Multiple sclerosis (MS) is a neurological, immune-mediated demyelinating disease that
affects people in the prime of life. Environmental, infectious, and genetic factors have been …

'Meningoencephalomyelitis of unknown origin'(MUO)-a collective term for a group of
clinically-indistinguishable (but pathologically distinct) autoimmune diseases of the CNS …

Background The global rising prevalence and incidence of multiple sclerosis (MS) has been
reported during the past decades. However, details regarding the evolution of MS burden …

Multiple sclerosis (MS) is the most common autoimmune disorder of the central nervous
system. It is a chronic, debilitating, demyelinating disease caused by an autoimmune attack …

Background In recent years dramatic changes in multiple sclerosis (MS) incidence have
been reported in different provinces in Iran. This study was conducted to assess MS …

Background Population-based studies estimating the epidemiology of paediatric-onset
multiple sclerosis (PoMS) are scarce. Methods We accessed population-based health …

Abstract Background Multiple Sclerosis (MS) represents the most common inflammatory
neurological disease causing disability in early adulthood. Childhood and adolescence …

Background Multiple sclerosis is an inflammatory demyelination process in the central
nervous system (CNS) causing neurological disability and poor quality of life. Currently, Thai …

Multiple sclerosis (MS) is the most frequent inflammatory and demyelinating disease of the
central nervous system (CNS). The underlying pathophysiology of MS is the destruction of …

Background: The rehabilitation process for multiple sclerosis (MS) patients is long and
complex, which can lead to reduced rehabilitation outcomes and reduced quality …